The Latin America, Middle East and Africa Medical Thawing System Market would witness market growth of 11.5% CAGR during the forecast period (2020-2026). The increasing number of surgeries and growing rates of hemorrhage-related conditions in these surgeries are boosting the growth of the medical thawing system. The demand for thawed blood to be more rapidly available for hemorrhage in different invasive surgeries has been rising. Besides, this factor is also a significant contributor to the growth of the market. Furthermore, the growing number of items launches and constant development in the features of the thawing system is also adding to the demand.
The demand for medical thawing systems in labs and blood banks has been rising, where it needs warming of items like complete blood, crystalloid infusion solution, and RBC before transfusion into a patient, is anticipated to boost the development of the market. Advances in technology in automated thawing systems at the point of care settings and growing demand for past thawing methods of frozen plasma in different surgical methods are the elements pushing the growth of this market. Also, the increasing use of thawed cells because of the high road accident rates, cancer, diabetes, and trauma cases are also some of the factors that boost the demand for the medical thawing system.
Based on Product Type, the market is segmented into Manual and Automated. Based on Sample Type, the market is segmented into Blood, Ovum, Semen, Embryo and Others. Based on End Use, the market is segmented into Based on End Use, the market is segmented into Blood Bank & Transfusion centers, Hospitals, Tissue Banks, Biotechnology & Pharma and Other End Uses. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
Free Valuable Insights: Medical Thawing System Market in LAMEA is expected to register a CAGR of 11.5% during the forecast period (2020-2026)
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include General Electric (GE) Co. (GE Healthcare), Thermo Fisher Scientific, Inc., Cardinal Health, Inc., Helmer Scientific, Inc., Sarstedt AG & Company, Boekel Scientific, Inc., Barkey GmbH & Co. KG, BioCision LLC, Sartorius AG and CytoTherm LP.
By Product Type
By Sample Type
By End-Use
By Country
Companies Profiled
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 